Aromatic herbs (rosemary) are easily integrated without excess
While B12 injections demonstrate excellent safety profiles, professional oversight ensures optimal outcomes while identifying individuals who may require modified treatment approaches or additional supportive therapies
The pharmacokinetics support once-weekly dosing thanks to a half-life of approximately 6 days, which means users can achieve consistent receptor activation without the peaks and valleys that destroy adherence
However, it is not recommended to take them for a long time or in excessive amounts to avoid adverse reactions
Kanhai KMS, Zuiker RGJA, Stavrakaki I, Gladdines W, Gaillard PJ, Klaassen ES, et al
The prescribing information does not list B12 deficiency as a recognised adverse effect, and clinical trials have not identified a direct mechanistic link between the medication and B12 status